Progressive massive fibrosis

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

WikiDoc Resources for

Progressive massive fibrosis

Articles

Most recent articles on Progressive massive fibrosis

Most cited articles on Progressive massive fibrosis

Review articles on Progressive massive fibrosis

Articles on Progressive massive fibrosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Progressive massive fibrosis

Images of Progressive massive fibrosis

Photos of Progressive massive fibrosis

Podcasts & MP3s on Progressive massive fibrosis

Videos on Progressive massive fibrosis

Evidence Based Medicine

Cochrane Collaboration on Progressive massive fibrosis

Bandolier on Progressive massive fibrosis

TRIP on Progressive massive fibrosis

Clinical Trials

Ongoing Trials on Progressive massive fibrosis at Clinical Trials.gov

Trial results on Progressive massive fibrosis

Clinical Trials on Progressive massive fibrosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Progressive massive fibrosis

NICE Guidance on Progressive massive fibrosis

NHS PRODIGY Guidance

FDA on Progressive massive fibrosis

CDC on Progressive massive fibrosis

Books

Books on Progressive massive fibrosis

News

Progressive massive fibrosis in the news

Be alerted to news on Progressive massive fibrosis

News trends on Progressive massive fibrosis

Commentary

Blogs on Progressive massive fibrosis

Definitions

Definitions of Progressive massive fibrosis

Patient Resources / Community

Patient resources on Progressive massive fibrosis

Discussion groups on Progressive massive fibrosis

Patient Handouts on Progressive massive fibrosis

Directions to Hospitals Treating Progressive massive fibrosis

Risk calculators and risk factors for Progressive massive fibrosis

Healthcare Provider Resources

Symptoms of Progressive massive fibrosis

Causes & Risk Factors for Progressive massive fibrosis

Diagnostic studies for Progressive massive fibrosis

Treatment of Progressive massive fibrosis

Continuing Medical Education (CME)

CME Programs on Progressive massive fibrosis

International

Progressive massive fibrosis en Espanol

Progressive massive fibrosis en Francais

Businness

Progressive massive fibrosis in the Marketplace

Patents on Progressive massive fibrosis

Experimental / Informatics

List of terms related to Progressive massive fibrosis

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Progressive Massive Fibrosis is also known as Complex Pneumoconiosis. It is a disease that almost entirely affects coal miners. The disease arises firstly through the deposition of coal dust within the lung, and then through the body's immunological reactions to the dust. If disease is to be classified as PMF, the lung must contain lesions which are at least 1 cm in size, although some authorities place the boundary at 2 cm. In PMF, lesions most commonly occupy the upper lobes of the lung. Another characteristic of PMF lesions is that they are black.[1] How factors cause disease is known as 'Pathogenesis'. The pathogenesis of PMF is complicated, but involves two main routes - an immunological route, and a mechanical route.

Immunologically, disease is caused primarily through the activity of lung macrophages, which phagocytose dust particles after their deposition. These macrophages seek to eliminate the dust particle through either the mucociliary mechanism, or through lymphatic vessels which drain the lungs. Macrophages also produce an inflammatory mediator known as interleukin-1 (IL-1), which is part of the immune systems first line defenses against infecting particles. IL-1 is responsible for 'activation' of local vasculature, causing endothelial cells to express certain cell adhesion molecules, which help the cells of the bodies immune system to migrate into tissues. Macrophages exposed to dust have been shown to have markedly decreased chemotaxis. Production of inflammatory mediators - and the tissue damage that ensues as an effect of this, as well as reduced motility of cells, is fundamental to the pathogenesis of pneumoconiosis and the accompanying inflammation, fibrosis, and emphysema.

There are also some mechanical factors involved in the pathogenesis of Complex Pneumoconiosis that should be considered. The most notable indications are the fact that the disease tends to develop in the upper lobe of the lung - especially on the right, and its common occurrence in taller individuals.

References

Occupational Lung Diseases, 3rd Edition, Morgan and Seaton http://pim.medicine.dal.ca/il1.htm


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Personal tools